Altered synaptic activity and neuronal network excitability have been reported in ALS/FTD patient-derived neurons and in C9-NRE-expressing in vivo models, DPR-expressing models, and C9orf72 ablation models. This evidence concerns the gene C9 and amyotrophic lateral sclerosis.